GlassScriptPhysician profile
Daryl K Potter
NPI 1295739050
$6,711.06
in general payments reported to CMS, 2019-2025
41 companies · $511 in 2025
The $511 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $636 · 2020: $632 · 2021: $1,701 · 2022: $701 · 2023: $1,455 · 2024: $1,075 · 2025: $511.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,743 · Travel and Lodging: $299.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,742.55 |
| Travel and Lodging | $298.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alpha Orthopedic Systems | $1,216.06 | 2021 | |
| Paratek Pharmaceuticals, INC. | $893.62 | 2020-2025 | Nuzyra |
| Organogenesis INC. | $714.11 | 2019-2025 | Puraply, Novachor, Puraply Am |
| Smith+Nephew, INC. | $684.82 | 2020-2024 | Grafix Pl, Stravix, Oasis |
| Treace Medical Concepts, INC. | $535.23 | 2023-2024 | |
| Tactile Systems Technology INC | $366.28 | 2019-2025 | Nimbl, Flexitouch Plus |
| Abbvie INC. | $332.92 | 2021-2025 | |
| Sebela Pharmaceuticals INC. | $237.47 | 2019-2023 | Naftin, Pramosone |
| Horizon Therapeutics Plc | $163.08 | 2019-2023 | Krystexxa |
| Zyla Life Sciences, INC. | $156.84 | 2019-2020 | |
| Stryker Corporation | $146.45 | 2023-2024 | Alphavent, Viaflow, Iconix |
| Kowa Pharmaceuticals America, INC. | $136.04 | 2022 | |
| Melinta Therapeutics, LLC | $108.11 | 2019-2022 | |
| Convatec INC. | $100.06 | 2024 | |
| Kerecis Limited | $92.15 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $84.35 | 2021-2024 | Senza |
| Allergan, INC. | $81.86 | 2020 | |
| Mimedx Group, INC. | $76.10 | 2024 | |
| Medtronic, INC. | $63.14 | 2022-2025 | Intellis Adaptivestim, Inceptiv |
| Pfizer INC. | $51.95 | 2019-2020 | |
| Vertex Pharmaceuticals Incorporated | $45.89 | 2024-2025 | |
| Encore Dermatology INC. | $42.81 | 2020 | |
| Amgen INC. | $33.73 | 2024-2025 | Krystexxa |
| Surgenex LLC | $28.45 | 2025 | Renograft, Surgraft, Pellograft |
| Alfasigma USA, INC. | $28.31 | 2022 | |
| Nabriva Therapeutics, Plc | $26.70 | 2021-2022 | |
| Next Science LLC | $26.47 | 2023 | Blastx, Xperience, Surgx |
| Celularity INC. | $24.00 | 2019 | |
| Bone Support INC. | $21.45 | 2022 | |
| Depuy Synthes Sales INC. | $21.24 | 2024 | Motoband |
| Mckesson Patient Care Solutions INC. | $20.15 | 2019 | |
| Medtronic Vascular, INC. | $20.09 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $18.66 | 2023 | Jublia |
| Abbott Laboratories | $16.82 | 2022 | |
| Blue Surgical LLC | $16.38 | 2025 | |
| La Jolla Pharmaceutical Company | $14.91 | 2020 | |
| Reprise Biomedical, INC. | $14.56 | 2024 | Miro3d |
| Globus Medical, INC. | $14.23 | 2025 | Senza |
| Paragon 28, INC. | $13.43 | 2020 | |
| Integra Lifesciences Corporation | $13.05 | 2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Orthofix Medical, INC. | $9.09 | 2019-2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daryl Potter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.